Longevity Core Concepts Library
Every article, presentation, spotlight, and news item we've tagged to Longevity Core Concepts.
Showing 1–24 of 331
Genomic precision medicine delays major disease by 20-30 years
Dr. Wei-Wu He, CEO of Human Longevity Inc., outlines a data-driven precision medicine platform built on genomic sequencing, multi-system phenotypic measurement, and longitudinal patient data to delay major age-related diseases by 20-30 years. The company has shifted from broad research ambitions to focused algorithmic development, now advancing collaborations that position it to scale personalized health optimization across populations.
The oldest old become longevity biotech’s new map
Human Longevity, Inc. and LEV Foundation are analyzing blood samples from centenarians and supercentenarians using multi-omic analysis to identify molecular and cellular patterns associated with exceptional longevity. This approach shifts the field from theoretical prediction toward evidence grounded in individuals who demonstrate sustained resilience across the human lifespan.
Can medicine outrun aging? Gerontologist says odds are improving
Longevity escape velocity (LEV) describes the point at which medical interventions extend life faster than aging progresses, requiring a repair-based approach to cellular and molecular damage rather than slowing decline alone. De Grey argues that demonstrating rejuvenation success in animal models will shift scientific consensus and accelerate translation to human therapies.
From hacks to health: why biohacking is growing up
The biohacking field is moving from supplementation and technological addition toward strategic simplification—recognizing that most modern interventions compensate for engineered-away baseline conditions like sunlight and movement rather than creating true upgrades. This shift reflects a maturing understanding that optimization requires knowing what to eliminate before adding tools.
Genetic and molecular factors underlying human longevity and epigenetic aging
Epigenetic aging—the divergence between chronological age and biological age—emerges as a measurable marker influenced by both genetic predisposition and modifiable molecular factors. Understanding these mechanisms provides actionable insight into why some individuals age more slowly at the cellular level and how interventions targeting epigenetic signatures may extend healthspan.
Human Longevity, Inc. to study centenarians with LEV Foundation
Human Longevity, Inc. and LEV Foundation are conducting multi-omic analyses of centenarians and supercentenarians to identify molecular biomarkers and pathways associated with exceptional longevity. This research bridges the gap between identifying what distinguishes the longest-lived individuals and developing interventions that could extend healthspan in broader populations.
Biologically Younger Individuals, as Identified by MARK‐AGE Biological Age Scores, Display a Distinct Favourable Blood Chemistry Profile Regardless of Age
Biological age, calculated from a 10-marker panel, correlates with HDL cholesterol, vitamin D, and immune function (CD4+ ratio) independently of chronological age. Subjects with lower biological age scores showed favorable values in these markers, suggesting they function as drivers of the aging process rather than mere correlates.
Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease
Proteomic analysis identified 311 plasma proteins whose expression patterns correlate with both chronological age and disease burden in older adults, representing candidate biomarkers of biological aging. These proteins suggest shared regulatory pathways between aging and chronic disease progression and may enable risk stratification and intervention monitoring.
Imaging-derived biological age across multiple organs links to mortality and aging-related health outcomes
Imaging-derived biological age—a measure of structural aging across multiple organs—independently predicts mortality and age-related disease risk beyond chronological age. This multi-organ assessment reveals that heterogeneous aging patterns across tissues provide clinically actionable information for longevity planning and intervention timing.
Epigenetic reprogramming reverses aging at cellular level
Epigenetic reprogramming represents a shift from static aging theories to a dynamic model where gene expression patterns—not DNA sequence itself—drive aging processes and can be therapeutically reversed. This reframes longevity interventions from inevitable decline management to targeted restoration of youthful cellular states.
The pursuit of understanding human longevity
Extreme longevity does not require genetic predisposition to exceptional health; rather, it emerges from multifactorial resilience combining protective genetics, metabolic efficiency, low systemic inflammation, and sustained lifestyle choices. This reframes centenarian health as an achievable outcome of integrated biological and environmental factors rather than an exceptional outlier.
Why precision medicine is changing how we treat aging
Precision medicine approaches that integrate regenerative therapies, peptides, and personalized diagnostics address the cellular foundations of chronic pain and accelerated aging rather than managing symptoms alone. This shift from symptom suppression to root-cause intervention reflects an emerging understanding that dysfunction across multiple physiological domains—inflammation, energy production, cellular cleanup, and tissue regeneration—converges in conditions labeled as chronic pain or age-related decline.
Elitra Health launches concierge primary care program
Elitra Health launched a concierge primary care program limiting physician panels to 35 patients and offering 24/7 access, same-day appointments, and integrated preventive care coordination. The model prioritizes continuity of care and early detection through advanced diagnostics and personalized wellness planning as an alternative to volume-based primary care.
AI-driven aging therapies target root biology over symptoms
AI-driven drug discovery is shifting medicine from treating downstream diseases to targeting aging biology itself, enabling personalized interventions tailored to individual biological signatures. This represents a fundamental reconceptualization of the therapeutic development process—from disease-specific pipelines to restoration of youthful cellular function.
Healthspan Replaces Lifespan in Insurance Risk Models
Insurance industry faces structural pressure to shift from mortality-focused actuarial models toward healthspan optimization as prevention, morbidity reduction, and health data reshape risk assessment. Insurers capable of actively shaping healthy aging outcomes—rather than passively financing disease burden—will gain competitive advantage in an aging demographic landscape.
Replacement‐Based Ageing Interventions for Systemic Rejuvenation: Shaping Longevity Science and Clinical Directions
Replacement-based interventions—which remove or export molecular, organellar, and cellular damage—offer a mechanistic approach to systemic rejuvenation that could extend healthy lifespan beyond conventional therapeutics. This framework integrates bioengineering strategies with regenerative approaches to address multiple forms of age-related damage simultaneously across tissues and regulatory networks.
Lipid-Epigenetic Crosstalk Drives Cellular Aging
Lipid metabolism and epigenetic regulation form a bidirectional communication network that drives cellular aging and age-related disease. The crosstalk between these pathways offers mechanistic insight into how metabolic dysfunction accelerates senescence and suggests multiple intervention points for longevity strategies.
Precision Biomarkers Replace Reactive Screening
Aman Clinics has launched Cenegenics' precision health program in Qatar, marking the first physician-led longevity model in the region. The program shifts from reactive treatment to proactive assessment of aging biomarkers and metabolic risk before symptoms develop, embedding preventive medicine into mainstream clinical care.
Metabolic Aging: From Clinical Management to Systems Optimization
Metabolic health is transitioning from a narrow clinical category to a multidisciplinary optimization target, driven by consumer-oriented virtual care, continuous monitoring technologies, and integrated behavioral support. This shift recognizes metabolic function as a primary determinant of biological aging and systemic health, not merely weight management.
Allen Law’s moonshot vision for the Longevity Century
Allen Law proposes that extending healthspan—not merely lifespan—is the central health challenge of the 21st century. The infrastructure and systems to support longer, stronger lives exist in scientific literature but remain inaccessible at scale; closing the 9.6-year gap between lifespan and healthspan requires proactive, preventive health built into daily life rather than reactive medicine.
Biological age and immunosenescence in Colombian centenarians
Colombian centenarians show delayed immunosenescence and younger biological age despite chronological longevity, suggesting that immune system resilience rather than mere longevity is the critical predictor of healthspan. This finding reframes centenarian research toward understanding which mechanisms preserve immune function across decades.
Why Reactive Medicine Fails Aging Populations
Current healthcare systems spend trillions managing late-life disease reactively through polypharmacy rather than preventing aging-related damage, creating an unsustainable economic crisis that demands a shift toward proactive health maintenance and rejuvenation science. This reallocation is not merely a health matter but an economic imperative tied to GDP growth, retirement security, and workforce productivity.
Stem Cell Turnover Drives Epigenetic Aging Across Species
A unified mathematical model of stem cell dynamics explains how DNA methylation patterns change with age across mammalian species, positioning stem cell turnover as a primary mechanism driving epigenetic aging. This work integrates diverse aging signatures into a coherent biological framework, shifting focus from methylation patterns themselves to the underlying cellular processes that generate them.
Some Researchers Choose Replacement Over Repair in Aging
Replacement-based interventions—substituting damaged cells, tissues, organs, and physiological systems with biological or synthetic alternatives—are emerging as a pragmatic complement to endogenous repair strategies in aging research. Multiple research organizations are advancing clinical applications ranging from stem cell therapies for structural injuries to bioprinted organs and genetic replacements derived from long-lived species.